WhiteSwell today announced positive data from 21 patients treated in a trial evaluating its eLym system for fluid removal. The company also announced FDA breakthrough device designation for the system. The agency also accepted it into its Total Product Lifecycle Advisory Program (TAP). Dr. Jan Biegus presented the data at the Technology and Heart Failure […]
whiteswell
WhiteSwell fluid removal system produces positive study results
WhiteSwell announced positive initial results from its DELTA-HF trial evaluating its eLym system for excess fluid removal. Galway, Ireland-based WhiteSwell designed eLym to treat acute decompensated heart failure (ADHF). It presented data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 in Cleveland, Ohio. The study evaluates the eLym minimally invasive catheter-based […]
Acute decompensated HF treatment device dev WhiteSwell raises $30m in Series B
Early stage device developer WhiteSwell said this week it closed a $30 million Series B round of financing to help support continued development and a pivotal study of the company’s technology intended to treat acute decompensated heart failure. The round was led by RA Capital Management and an InCube Ventures syndicate and joined by other […]
